Lysyl oxidase-like 2 as a predictor of hepatocellular carcinoma in patients with hepatitis C virus after sustained virological response

Lysyl oxidase-like 2 as a predictor of hepatocellular carcinoma in patients with hepatitis C virus after sustained virological response

Abstract Lysyl oxidase-like 2 (LOXL2) mediates the crosslinking of extracellular collagen, reflecting qualitative changes in liver fibrosis. This study aimed to validate the utility of serum LOXL2 levels as a predictive biomarker for the development of hepatocellular carcinoma (HCC) in patients with...

Full description

Bibliographic Details
Main Authors: Takeshi Chida, Kazuyoshi Ohta, Hidenao Noritake, Masahiro Matsushita, Gou Murohisa, Fujito Kageyama, Yuzo Sasada, Tatsuki Oyaizu, Minoru Tsugiki, Katsutoshi Tamakoshi, Takeyuki Nakajima, Takafumi Suda, Kazuhito Kawata
Format: Article
Language:English
Published: Nature Portfolio 2024-05-01
Series:Scientific Reports
Subjects:
Lysyl oxidase-like 2 (LOXL2)
Hepatocellular carcinoma (HCC)
Hepatitis C virus (HCV)
Sustained virological response (SVR)
Alpha-fetoprotein (AFP)
Online Access:https://doi.org/10.1038/s41598-024-61366-y

Internet

https://doi.org/10.1038/s41598-024-61366-y

Similar Items